Search

Author/Creator Forsten, Aino

1. Effectiveness of the 10-Valent Pneumococcal Nontypeable Haemophilus influenzae Protein D–Conjugated Vaccine (PHiD-CV) Against Carriage and Acute Otitis Media—A Double-Blind Randomized Clinical Trial in Finland. (28th April 2016)

Authors:
Vesikari, Timo; Forsten, Aino; Seppä, Ilkka; Kaijalainen, Tarja; Puumalainen, Taneli; Soininen, Anu; Traskine, Magali; Lommel, Patricia; Schoonbroodt, Sonia; Hezareh, Marjan; Moreira, Marta; Borys, Dorota; Schuerman, Lode
Journal:
Journal of the Pediatric Infectious Diseases Society
Issue:
Volume 5:Number 3(2016:Sep.)
Page Start:
237
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Immunogenicity and safety of an investigational quadrivalent meningococcal conjugate vaccine administered as a booster dose in children vaccinated against meningococcal disease 3 years earlier as toddlers: A Phase III, open-label, multi-center study. Issue 1 (31st December 2022)

Authors:
Piazza, Franco M.; Virta, Miia; Paassilta, Marita; Ukkonen, Benita; Ahonen, Anitta; Esteves-Jaramillo, Alejandra; Forsten, Aino; Seppa, Ilkka; Ding, Jian; Neveu, David; Jordanov, Emilia; Dhingra, Mandeep S.
Journal:
Human vaccines & immunotherapeutics
Issue:
Volume 18:Issue 1(2022)
Page Start:
1
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. 987. Repeated Exposure to an Adjuvanted Quadrivalent Subunit Influenza Virus Vaccine (aQIV): A Randomized, Observer Blind, Multicenter Study. (26th November 2018)

Authors:
Daly, Wendy; Ramsey, Keith; Forsten, Aino; Heijnen, Esther; Leav, Brett; Oberye, Janine; Zhang, Bin; Pacciarini, Filippo; Vesikari, Timo
Journal:
Open forum infectious diseases
Issue:
Volume 5(2018)Supplement 1
Page Start:
S292
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Antibody persistence up to 5 years after vaccination of toddlers and children between 12 months and 10 years of age with a quadrivalent meningococcal ACWY-tetanus toxoid conjugate vaccine. Issue 1 (2nd January 2016)

Authors:
Vesikari, Timo; Forsten, Aino; Bianco, Veronique; Van der Wielen, Marie; Miller, Jacqueline M
Journal:
Human vaccines & immunotherapeutics
Issue:
Volume 12:Issue 1(2016)
Page Start:
132
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Immunogenicity and safety of an investigational quadrivalent meningococcal conjugate vaccine administered as a booster dose in children vaccinated against meningococcal disease 3 years earlier as toddlers: A Phase III, open-label, multi-center study. Issue 1 (31st January 2022)

Authors:
Piazza, Franco M.; Virta, Miia; Paassilta, Marita; Ukkonen, Benita; Ahonen, Anitta; Esteves-Jaramillo, Alejandra; Forsten, Aino; Seppa, Ilkka; Ding, Jian; Neveu, David; Jordanov, Emilia; Dhingra, Mandeep S.
Journal:
Human vaccines & immunotherapeutics
Issue:
Volume 18:Issue 1(2022)
Page Start:
1
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Immunogenicity, Safety and Antibody Persistence of a Booster Dose of Quadrivalent Meningococcal ACWY-tetanus Toxoid Conjugate Vaccine Compared with Monovalent Meningococcal Serogroup C Vaccine Administered Four Years After Primary Vaccination Using the Same Vaccines. Issue 12 (December 2015)

Authors:
Vesikari, Timo; Forsten, Aino; Bianco, Veronique; Van der Wielen, Marie; Miller, Jacqueline M.
Journal:
Pediatric infectious disease journal
Issue:
Volume 34:Issue 12(2015)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗